Racial representation in multicenter clinical trials leading to drug approvals for gynecological cancer indications by the US Food and Drug Administration (FDA).
Year: 2024
Type: conference-abstract
Source: JCO Oncology Practice
Language: English
Topic: Ethics in Clinical Research
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4402985363
